术前3个月内关节内注射糖皮质激素可能增加后续关节置换术后深部感染风险:一项Meta分析
该Meta分析纳入11项回顾性比较研究、173465例髋或膝关节置换,评估术前关节内糖皮质激素注射与假体周围关节感染的关系。总体感染风险无差异(OR 1.22,95%CI 0.95-1.58,p=0.12),但术前3个月内注射者感染风险升高(OR 1.39,95%CI 1.04-1.87,p=0.03)。作者建议不对3个月内接受过关节内糖皮质激素注射的患者行全关节置换术。
要点
- 总体而言,任何时机关节内糖皮质激素注射与假体周围关节感染风险无显著差异(OR 1.22,95%CI 0.95-1.58,p=0.12)。
- 术前3个月内关节内注射糖皮质激素与后续关节置换术后假体周围关节感染风险升高相关(OR 1.39,95%CI 1.04-1.87,p=0.03)。
- 术前3至6个月或6至12个月注射者的感染风险无显著差异。
核心结论
- 当前证据提示,关节置换术前3个月内同侧关节内糖皮质激素注射与后续关节置换术后假体周围关节感染风险升高相关。
- 作者建议不对3个月内接受过关节内糖皮质激素注射的患者行全关节置换术。
- 仍需来自登记系统、国家数据库或保险公司数据的高质量研究来确认和扩展本研究发现。
研究设计与样本
- 检索PubMed、Embase、Cochrane Library和Web of Science数据库自建库至2021年7月,纳入英文比较性研究。
- 纳入11项回顾性比较研究,来自4个国家,其中10项报告了具体诊断标准,1项未报告。
- 纳入数据包括173465例髋或膝关节置换、73049例注射和100416例对照患者。
- 采用纽卡斯尔-渥太华质量评估量表评价方法学质量,文献评分为6至7分(量表总分0至9分,评分越高代表研究质量越好)。
- Egger检验未发现发表偏倚证据,异质性检验普遍发现存在异质性,故Meta分析采用随机效应模型。
主要发现
- 总体而言,注射组与对照组假体周围关节感染风险无差异(OR 1.22,95%CI 0.95-1.58,p=0.12)。
- 亚组分析中,术前3个月内在膝或髋关节接受关节内糖皮质激素注射者术后假体周围关节感染OR较高(OR 1.39,95%CI 1.04-1.87,p=0.03)。
- 术前3至6个月注射者感染风险无差异(OR 1.19,95%CI 0.95-1.48,p=0.13);术前6至12个月注射者感染风险亦无差异。
关键数值与推荐
- 总体假体周围关节感染:OR 1.22(95%CI 0.95-1.58;p=0.12)。
- 术前3个月内注射亚组假体周围关节感染:OR 1.39(95%CI 1.04-1.87;p=0.03)。
- 术前3至6个月注射亚组假体周围关节感染:OR 1.19(95%CI 0.95-1.48;p=0.13)。
- 证据等级:III级,治疗性研究。
临床怎么用
- 作者建议不对3个月内接受过关节内糖皮质激素注射的患者行全关节置换术。
局限性
- 纳入的11项研究均为回顾性比较研究。
- 异质性检验普遍发现存在异质性,故Meta分析采用随机效应模型。
- 仍需来自登记系统、国家数据库或保险公司数据的高质量研究来确认和扩展本研究发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intra-articular injections containing a corticosteroid are used frequently, and periprosthetic joint infection is a serious complication after total joint arthroplasty. There is debate regarding whether intra-articular corticosteroid injections before arthroplasty increase periprosthetic joint infection after surgery. QUESTIONS/PURPOSES: (1) Does a previous intra-articular corticosteroid injection increase the odds of infection after subsequent hip or knee arthroplasty? (2) Does this risk vary based on how soon before the arthroplasty (such as less than 3 months before surgery) the injection is administered? METHODS: Using the PubMed, Embase, Cochrane Library, and Web of Science databases from inception to July 2021, we searched for comparative studies in English on patients who received intra-articular corticosteroid injections before arthroplasty and that tracked the frequency of infection after arthroplasty. We extracted data on the risk of infection after subsequent joint arthroplasty. The keywords included "corticosteroid," "steroid," "arthroplasty," "knee replacement," and "hip replacement." Eleven retrospective, comparative studies from four countries were included, of which 10 reported the specific diagnosis criteria and one did not. These articles included data on 173,465 arthroplasties in the hip or knee, as well as of 73,049 injections and 100,416 control patients. The methodologic quality of the included studies was evaluated according to the Newcastle-Ottawa Quality Assessment Scale; the articles' scores ranged from 6 to 7 (the score itself spans 0 to 9, with higher scores representing better study quality). We found no evidence of publication bias based on the Egger test, and tests of heterogeneity generally found heterogeneity, so a random-effects model was used of our meta-analyses. A meta-analysis was performed with Review Manager 5.3 software and Stata version 12.0 software. RESULTS: Overall, there were no differences in the odds of periprosthetic joint infection between the injection group and the control group among patients who received any kind of injection (odds ratio 1.22 [95% CI 0.95 to 1.58]; p = 0.12). However, in a subgroup analysis, there was a higher OR for postoperative PJI in patients with an intra-articular corticosteroid injection in the knee or hip within 3 months (OR 1.39 [95% CI 1.04 to 1.87]; p = 0.03). There were no differences in the infection risk in patients who had injections between 3 and 6 months before arthroplasty (OR 1.19 [95% CI 0.95 to 1.48]; p = 0.13) or between 6 and 12 months before arthroplasty. CONCLUSION: The current evidence suggests ipsilateral intra-articular corticosteroid injections within 3 months before arthroplasty were associated with an increased risk of periprosthetic joint infection during subsequent joint arthroplasty. We recommend against performing total joint arthroplasty on a patient who has received an intra-articular corticosteroid injection within 3 months. Further high-quality studies on this topic from registries, national databases, or insurance company data are still required to confirm and extend our findings. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Lai Q, Cai K, Lin T, et al. Prior Intra-articular Corticosteroid Injection Within 3 Months May Increase the Risk of Deep Infection in Subsequent Joint Arthroplasty: A Meta-analysis. Clin Orthop Relat Res. 2021. PMID: 34919065. doi:10.1097/CORR.0000000000002055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。